Semaglutide, Tirzepatide, Retatrutide and Cagrilintide are often lumped together, but they are not doing the same thing. : r Wegovy Dozens of new obesity drugs are coming: these are the ones to watch CagriSema, Novo Nordisk's Latest Obesity Drug Offering, Disappoints Investors with Trial Results Xtalks An investigational injectable that only requires dosing once every 4 weeks led to substantial weight loss in patients with obesity with or without type 2 diabetes, a phase II randomized trial showed.,